ExitOdds Method

Ranking · Summer 2012 · B2B

Benchling

Unlocking the power of biotech with modern software for modern science

9.2%

odds of being acquired in the next two years

1.3× the average (6.8%)

#671 of 4,339 active YC companies · top 16%

Team of 750 · San Francisco, CA, USA

Raises the odds

↑ industry: B2B

↑ tag: SaaS

↑ “modern” in its one-liner

↑ based in United States of America

Lowers the odds

↓ tag: Biotech

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Benchling's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub